The webpage discusses EABR (exosome-associated AAV-based recombinant) nanoparticles as a platform technology for developing hybrid mRNA vaccines. It emphasizes the potential of EABR nanoparticles in enhancing the efficiency and delivery of mRNA vaccines by using a novel, biocompatible platform that can be customized to improve vaccine performance.EABR nanoparticles provide significant... https://mrna.creative-biolabs.com/eabr-nanoparticles-as-a-platform-technology-for-hybrid-mrna-vaccine.htm